{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:50:57Z","timestamp":1740167457736,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40121-024-01017-x","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T02:01:50Z","timestamp":1721786510000},"page":"2001-2015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents\/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-8865","authenticated-orcid":false,"given":"Shahina","family":"Begum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-2855","authenticated-orcid":false,"given":"Eliazar Sabater","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-999X","authenticated-orcid":false,"given":"Oscar Herrera","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2860-1500","authenticated-orcid":false,"given":"Cindy","family":"Burman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Yun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-5507","authenticated-orcid":false,"given":"Elise","family":"Kuylen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-451X","authenticated-orcid":false,"given":"Hiral","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-3389","authenticated-orcid":false,"given":"Zeki","family":"Kocaata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"2 Suppl","key":"1017_CR1","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","volume":"59","author":"F Martin\u00f3n-Torres","year":"2016","unstructured":"Martin\u00f3n-Torres F. Deciphering the burden of meningococcal disease: conventional and under-recognized elements. J Adolesc Health. 2016;59(2 Suppl):S12-20. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.03.041.","journal-title":"J Adolesc Health"},{"key":"1017_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Revising the Adolescent Meningococcal Vaccine Schedule: Term of Reference and Considerations. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2024-02-28-29\/02-Meningitis-Schillie-508.pdf. Accessed 8 Apr 2024."},{"key":"1017_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal disease: Surveillance (Figure 2 data). https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html#trends. Accessed 12 Feb 2024."},{"key":"1017_CR4","unstructured":"Centers for Disease Control and Prevention (CDC). Enhanced meningococcal disease surveillance report. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2021.pdf. Accessed 12 Feb 2024."},{"issue":"1","key":"1017_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","volume":"22","author":"J Shen","year":"2022","unstructured":"Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application\u2014a systematic and clinical review. BMC Public Health. 2022;22(1):1078. https:\/\/doi.org\/10.1186\/s12889-022-13342-2.","journal-title":"BMC Public Health"},{"key":"1017_CR6","unstructured":"World Health Organization (WHO). Meningitis - Key facts. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/meningitis. Accessed 11 Jan 2023."},{"issue":"8","key":"1017_CR7","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.4161\/hv.29303","volume":"10","author":"G Krishnarajah","year":"2014","unstructured":"Krishnarajah G, Carroll C, Priest J, Arondekar B, Burstin S, Levin M. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006\u20132010. Hum Vaccin Immunother. 2014;10(8):2460\u20137. https:\/\/doi.org\/10.4161\/hv.29303.","journal-title":"Hum Vaccin Immunother"},{"key":"1017_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1471-2458-12-338","volume":"12","author":"A Doroshenko","year":"2012","unstructured":"Doroshenko A, Hatchette J, Halperin SA, MacDonald NE, Graham JE. Challenges to immunization: the experiences of homeless youth. BMC Public Health. 2012;12:338. https:\/\/doi.org\/10.1186\/1471-2458-12-338.","journal-title":"BMC Public Health"},{"key":"1017_CR9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2130","author":"SA Mbaeyi","year":"2019","unstructured":"Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal disease among college-aged young adults: 2014\u20132016. Pediatrics. 2019. https:\/\/doi.org\/10.1542\/peds.2018-2130.","journal-title":"Pediatrics"},{"issue":"5","key":"1017_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cid\/ciy183","volume":"67","author":"D Bloch","year":"2018","unstructured":"Bloch D, Murray K, Peterson E, et al. Sex difference in meningococcal disease mortality, New York City, 2008\u20132016. Clin Infect Dis. 2018;67(5):760\u20139. https:\/\/doi.org\/10.1093\/cid\/ciy183.","journal-title":"Clin Infect Dis"},{"key":"1017_CR11","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1017\/s0950268823000328","volume":"151","author":"C Pardo de Santayana","year":"2023","unstructured":"Pardo de Santayana C, Tin Tin Htar M, Findlow J, Balmer P. Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review. Epidemiol Infect. 2023;151:e57. https:\/\/doi.org\/10.1017\/s0950268823000328.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"1017_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","volume":"81","author":"SR Parikh","year":"2020","unstructured":"Parikh SR, Campbell H, Bettinger JA, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483\u201398. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.079.","journal-title":"J Infect"},{"key":"1017_CR13","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal vaccine recommendations. https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/hcp\/recommendations.html. Accessed 12 Feb 2024."},{"key":"1017_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2023.11.394","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Bunniran S, Mond T, et al. United States physicians\u2019 knowledge, attitudes, and practices regarding meningococcal vaccination for healthy adolescents and young adults. J Adolesc Health. 2024. https:\/\/doi.org\/10.1016\/j.jadohealth.2023.11.394.","journal-title":"J Adolesc Health"},{"issue":"34","key":"1017_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","volume":"72","author":"C Pingali","year":"2023","unstructured":"Pingali C, Yankey D, Elam-Evans LD, et al. Vaccination coverage among adolescents aged 13\u201317 years\u2014National Immunization Survey-Teen, United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(34):912\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7234a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1017_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/INF.0000000000003033","volume":"40","author":"J Fergie","year":"2021","unstructured":"Fergie J, Howard A, Huang L, Srivastava A. Implementation Experience With Meningococcal Serogroup B Vaccines in the United States: Impact of a Nonroutine Recommendation. Pediatr Infect Dis J. 2021;40(3):269\u201375. https:\/\/doi.org\/10.1097\/INF.0000000000003033.","journal-title":"Pediatr Infect Dis J"},{"key":"1017_CR17","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccination Programs - General Best Practice Guidelines for Immunization. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/programs.html. Accessed 6 May 2024."},{"key":"1017_CR18","unstructured":"US Department of Health and Human Services. Healthy People 2030 https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/vaccination\/increase-proportion-adults-age-19-years-or-older-who-get-recommended-vaccines-iid-d03. Accessed 6 May 2024."},{"issue":"5","key":"1017_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.vaccine.2015.11.075","volume":"34","author":"HS Marshall","year":"2016","unstructured":"Marshall HS, Chen G, Clarke M, Ratcliffe J. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment. Vaccine. 2016;34(5):671\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.075.","journal-title":"Vaccine"},{"issue":"7","key":"1017_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181073","volume":"12","author":"B Wang","year":"2017","unstructured":"Wang B, Chen G, Ratcliffe J, Afzali HHA, Giles L, Marshall H. Adolescent values for immunisation programs in Australia: a discrete choice experiment. PLoS ONE. 2017;12(7): e0181073. https:\/\/doi.org\/10.1371\/journal.pone.0181073.","journal-title":"PLoS ONE"},{"issue":"1","key":"1017_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijpp.12002","volume":"21","author":"P Naik-Panvelkar","year":"2013","unstructured":"Naik-Panvelkar P, Armour C, Saini B. Discrete choice experiments in pharmacy: a review of the literature. Int J Pharm Pract. 2013;21(1):3\u201319. https:\/\/doi.org\/10.1111\/ijpp.12002.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"1017_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"F Reed Johnson","year":"2013","unstructured":"Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3\u201313. https:\/\/doi.org\/10.1016\/j.jval.2012.08.2223.","journal-title":"Value Health"},{"issue":"4","key":"1017_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/11539650-000000000-00000","volume":"3","author":"D Marshall","year":"2010","unstructured":"Marshall D, Bridges JF, Hauber B, et al. Conjoint analysis applications in health\u2014how are studies being designed and reported?: An Update on Current Practice in the Published Literature between 2005 and 2008. Patient. 2010;3(4):249\u201356. https:\/\/doi.org\/10.2165\/11539650-000000000-00000.","journal-title":"Patient"},{"issue":"4","key":"1017_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300\u201315. https:\/\/doi.org\/10.1016\/j.jval.2016.04.004.","journal-title":"Value Health"},{"key":"1017_CR25","doi-asserted-by":"publisher","unstructured":"Begum S, Cabrera ES, Herrera-Restrepo O, et al. 1150. Invasive meningococcal disease vaccination \u2013 a targeted literature review of adolescents and parents\/caregivers\u2019 preferences IDWeek Annual Meeting, 11\u201315 October 2023 Boston, MA, United States. Open Forum Infect Dis. 10 (Suppl 2) https:\/\/doi.org\/10.1093\/ofid\/ofad500.991.","DOI":"10.1093\/ofid\/ofad500.991"},{"key":"1017_CR26","doi-asserted-by":"publisher","unstructured":"Begum S, Cabrera ES, Hortobagyi L, et al. 1137. The Value of Invasive Meningococcal Disease Combination Vaccine \u2013 a Qualitative Study of Adolescents and Parents\/Caregivers\u2019 Preferences in the US IDWeek Annual Meeting, 11\u201315 October 2023 Boston MA, United States. Open Forum Infect Dis 10 (Suppl 2) https:\/\/doi.org\/10.1093\/ofid\/ofad500.978.","DOI":"10.1093\/ofid\/ofad500.978"},{"key":"1017_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/002224379403100408","author":"W Kuhfeld","year":"1994","unstructured":"Kuhfeld W, Tobias R, Garratt M. Efficient experimental design with marketing research applications. J Mark Res. 1994. https:\/\/doi.org\/10.1177\/002224379403100408.","journal-title":"J Mark Res"},{"key":"1017_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-024-00677-8","author":"J Coulter","year":"2024","unstructured":"Coulter J, Whichello C, Heidenreich S, et al. From qualitative research to quantitative preference elicitation: an example in invasive meningococcal disease. Patient. 2024. https:\/\/doi.org\/10.1007\/s40271-024-00677-8.","journal-title":"Patient"},{"issue":"1","key":"1017_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1186\/s12879-021-06398-9","volume":"21","author":"ME Diks","year":"2021","unstructured":"Diks ME, Hiligsmann M, van der Putten IM. Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments. BMC Infect Dis. 2021;21(1):879. https:\/\/doi.org\/10.1186\/s12879-021-06398-9.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1017_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387\u2013409. https:\/\/doi.org\/10.1038\/s41573-023-00670-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1017_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3316","volume":"3","author":"CJ Granade","year":"2020","unstructured":"Granade CJ, McCord RF, Bhatti AA, Lindley MC. State policies on access to vaccination services for low-income adults. JAMA Netw Open. 2020;3(4): e203316. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3316.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1017_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","volume":"70","author":"PJ Lu","year":"2021","unstructured":"Lu PJ, Hung MC, Srivastav A, et al. Surveillance of vaccination coverage among adult populations -United States, 2018. MMWR Surveill Summ. 2021;70(3):1\u201326. https:\/\/doi.org\/10.15585\/mmwr.ss7003a1.","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"1017_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s40121-023-00793-2","volume":"12","author":"O Herrera-Restrepo","year":"2023","unstructured":"Herrera-Restrepo O, Kuang Y, D\u2019Angelo J, Bekkat-Berkani R, Clements DE, Uyei J. Determinants of meningococcal vaccination coverage and adherence: a targeted literature review supporting a 16-year-old healthcare visit. Infect Dis Ther. 2023;12(5):1265\u201382. https:\/\/doi.org\/10.1007\/s40121-023-00793-2.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1017_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/03007995.2023.2285366","volume":"40","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Zhou Z, Krishnan A, et al. Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults. Curr Med Res Opin. 2024;40(1):125\u201340. https:\/\/doi.org\/10.1080\/03007995.2023.2285366.","journal-title":"Curr Med Res Opin"},{"key":"1017_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.984","author":"O Herrera-Restrepo","year":"2023","unstructured":"Herrera-Restrepo O, Kwiatkowska M, Ndegwa N, Poston S, Ganz M. 1143. Meningococcal vaccination coverage disparities in the United States: an analysis with 2016\u20132021 National Immunization Survey-Teen Data. Open Forum Infect Dis. 2023;10(Suppl 2):ofad500.984. https:\/\/doi.org\/10.1093\/ofid\/ofad500.984.","journal-title":"Open Forum Infect Dis"},{"key":"1017_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.977","author":"S Begum","year":"2023","unstructured":"Begum S, Herrera-Restrepo O, Rolland C, Purushotham S, Hortobagyi L, Kocaata Z. 1136. A systematic literature review of disparities that may influence health equity in invasive meningococcal disease prevention in the US. Open Forum Infect Dis. 2023. https:\/\/doi.org\/10.1093\/ofid\/ofad500.977.","journal-title":"Open Forum Infect Dis"},{"key":"1017_CR37","unstructured":"Herrera-Restrepo O, Kwiatkowska M, Ndegwa N, Poston S, Ganz M Poster. Meningococcal vaccination coverage disparities in the United States: an analysis with 2016\u20132021 National Immunization Survey - Teen data IDWeek, October 2023, Boston, MA, USA, https:\/\/gskusmedicalaffairs.com\/docviewer.html?cmd=GSKMedicalInformation&medcommid=MED--US-11556&token=23108-d41ea6c1-c0fa-429f-ac0c-198f2ac6d1f3&dns=gsk-medcomms.veevavault.com."},{"issue":"4","key":"1017_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.vaccine.2018.11.078","volume":"37","author":"NE Basta","year":"2019","unstructured":"Basta NE, Becker AB, Li Q, Nederhoff D. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2019;37(4):670\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.078.","journal-title":"Vaccine"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01017-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:17:52Z","timestamp":1724455072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01017-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"type":"print","value":"2193-8229"},{"type":"electronic","value":"2193-6382"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shahina Begum, Eliazar Sabater Cabrera, Oscar Herrera Restrepo, Cindy Burman, Woo-Yun Sohn, Elise Kuylen, Hiral Shah, and Zeki Kocaata are employed by and hold financial equities in GSK. The authors declare no other financial and non-financial relationships and activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional review board approval was received on 11\/27\/2022 from WCG IRB (IRB Tracking number 20226172). All survey respondents provided informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}